Insights and Perspectives on the Competence of Nanotechnology: Emerging Standards in the Post-Pandemic Context of COVID-19
Sheeba S*, Murugan M and Suman Sankar AS
ABSTRACT
The outbreak of coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), underscored the urgent need for innovative therapeutic strategies. Despite nearly two decades of recurring coronavirus threats such as SARS-CoV and MERS-CoV, no specific and universally effective antiviral drugs have been approved for this viral family. This gap has highlighted the importance of exploring novel approaches alongside traditional therapies. Nanotechnology, particularly Nano medicine, has emerged as a promising field due to its potential applications in diagnostics, drug delivery, vaccine development, and targeted therapy. Current global research efforts are actively investigating how nanoscale interventions can enhance the prevention, management, and treatment of COVID-19, while also setting new standards for post-pandemic preparedness. This article provides insights and perspectives on the competence of nanotechnology, emphasizing its evolving role and the emerging norms that may shape healthcare innovation in the post-pandemic era.
